Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Antiplatelets Duration and SAPT

Presenter: Marco Valgimigli

October 26, 2025

Presentation Cardiovascular Interventions 2020

Anatomic Complexity and Choice of P2Y12: Cases for the Panel

Presenter: Duane Pinto

November 13, 2020

Presentation JIM 2017

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Presenter: Giuseppe Tarantini

February 10, 2017

Presentation JIM 2016

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Presenter: Roxana Mehran

February 11, 2016

Presentation CCVVC 2015

Data for Recent Antiplatelets and Antithrombotics

Presenter: Deepak L. Bhatt

June 17, 2015

Presentation VEINS 2014

Antiplatelets and Anticoagulation Post Intervention: Surveillance and Predictors of Failure

Presenter: Nicolas W. Shammas

October 10, 2014

Presentation TCT 2014

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Presenter: Matthew J. Price, Michael D. Ezekowitz

September 15, 2014

Presentation VEINS 2013

Antiplatelets, Anticoagulation Post Intervention and Surveillance

Presenter: John R. Bartholomew

September 20, 2013

Presentation

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Presenter: M. Lamberts

June 12, 2013

Presentation ACVS 2012

Which Antiplatelets to Use for PCI?

Presenter: Dev Pahlajani

August 04, 2012

Advertisement

ACS Pharma Trials On The Horizon: Antiplatelets Duration and SAPT

Anatomic Complexity and Choice of P2Y12: Cases for the Panel

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Data for Recent Antiplatelets and Antithrombotics

Antiplatelets and Anticoagulation Post Intervention: Surveillance and Predictors of Failure

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Antiplatelets, Anticoagulation Post Intervention and Surveillance

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Which Antiplatelets to Use for PCI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content